Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8952)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2020 (publication date) through Oct 4, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sultan K, Mone A, Durbin L, Khuwaja S, Swaminath A. Review of inflammatory bowel disease and COVID-19. World J Gastroenterol 2020; 26(37): 5534-5542 [PMID: 33088153 DOI: 10.3748/wjg.v26.i37.5534] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i37/5534.htm |
| Number | Citing Articles |
| 1 |
Richard Taylor, Daniel Mallon. COVID-19 and Pediatric Gastroenterology. Pediatric Clinics of North America 2021; 68(6): 1157 doi: 10.1016/j.pcl.2021.07.003
|
| 2 |
Shao Liu, Mi-Mi Tang, Jie Du, Zhi-Cheng Gong, Shu-Sen Sun. COVID-19 in gastroenterology and hepatology: Lessons learned and questions to be answered. World Journal of Clinical Cases 2021; 9(17): 4199-4209 doi: 10.12998/wjcc.v9.i17.4199
|
| 3 |
Marouf Alhalabi, Kamal Alaa Eddin, Khaled Cheha, Ahmad Abbas. Subcutaneous golimumab induced and maintained clinical response in a child with a biological-experienced steroid-refractory flare of ulcerative colitis. Medicine 2021; 100(38): e27283 doi: 10.1097/MD.0000000000027283
|
| 4 |
Xiaomei Wang, Guoliang Zhou, Wanwan Zhou, Xin Wang, Xiao Wang, Chenggui Miao. Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease. Pharmaceutics 2021; 13(10): 1644 doi: 10.3390/pharmaceutics13101644
|
| 5 |
Javier del Hoyo, Mónica Millán, Alejandro Garrido-Marín, Pilar Nos, Manuel Barreiro-de Acosta, Luis Bujanda, Fernando de la Portilla, Mariam Aguas. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?. Gastroenterología y Hepatología (English Edition) 2022; 45(9): 697 doi: 10.1016/j.gastre.2021.08.004
|
| 6 |
Benedetto Neri, Giorgia D’Agostini, Silvia Salvatori, Michelangela Mossa, Federica Bettin, Roberto Mancone, Irene Marafini, Elisabetta Lolli, Emma Calabrese, Giovanni Monteleone, Livia Biancone. Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term. European Journal of Gastroenterology & Hepatology 2023; 35(9): 948 doi: 10.1097/MEG.0000000000002554
|
| 7 |
Daniele Napolitano, Linda Galasso, Giuseppe Privitera, Giuseppe Morana, Arianna Bardelli, Rita Sinatora, Maria Francesca Onidi, Maria Teresa Lombardi, Nicoletta Orgiana, Valeria Amatucci, Martina Strazzeri, Elisa Schiavoni, Laura Turchini, Alessandra Guarini, Carlo Romano Settanni, Alessandro Armuzzi, Franco Scaldaferri. The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic. Gastrointestinal Nursing 2022; 20(2): 40 doi: 10.12968/gasn.2022.20.2.40
|
| 8 |
Kristian Marling Moum, Bjørn Moum, Randi Opheim. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives’ on COVID-19 and health care service during the pandemic. Scandinavian Journal of Gastroenterology 2021; 56(5): 545 doi: 10.1080/00365521.2021.1901308
|
| 9 |
Siva Sundara Kumar Durairajan, Abhay Kumar Singh, Udhaya Bharathy Saravanan, Mayurikaa Namachivayam, Moorthi Radhakrishnan, Jian-Dong Huang, Rahul Dhodapkar, Hongjie Zhang. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications. Viruses 2023; 15(6): 1231 doi: 10.3390/v15061231
|
| 10 |
Javier del Hoyo, Mónica Millán, Alejandro Garrido-Marín, Pilar Nos, Manuel Barreiro-de Acosta, Luis Bujanda, Fernando de la Portilla, Mariam Aguas. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?. Gastroenterología y Hepatología 2022; 45(9): 697 doi: 10.1016/j.gastrohep.2021.08.006
|
| 11 |
Simcha Weissman, Muhammad Aziz, Wade-Lee Smith, Sameh Elias, Arun Swaminath, Joseph D. Feuerstein. Safety of biologics in inflammatory bowel disease patients with COVID-19. International Journal of Colorectal Disease 2021; 36(9): 2051 doi: 10.1007/s00384-021-03977-9
|
| 12 |
Katerina G Oikonomou, Panagiotis Papamichalis, Tilemachos Zafeiridis, Maria Xanthoudaki, Evangelia Papapostolou, Asimina Valsamaki, Konstantinos Bouliaris, Michail Papamichalis, Marios Karvouniaris, Panagiotis J Vlachostergios, Apostolia-Lemonia Skoura, Apostolos Komnos. Gastroenterology and liver disease during COVID-19 and in anticipation of post-COVID-19 era: Current practice and future directions. World Journal of Clinical Cases 2021; 9(19): 4918-4938 doi: 10.12998/wjcc.v9.i19.4918
|
| 13 |
Fei Chen, Zhiqing Dai, Chaofan Huang, Huiran Chen, Xinyi Wang, Xinya Li. Gastrointestinal Disease and COVID-19: A Review of Current Evidence. Digestive Diseases 2022; 40(4): 506 doi: 10.1159/000519412
|
| 14 |
Elham Tabesh, Maryam Soheilipour, Mohammad Rezaeisadrabadi, Elahe Zare-Farashbandi, Razieh Sadat Mousavi-Roknabadi. Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02460-1
|
| 15 |
Lu Lu, Le-Ping Liu, Rong Gui, Hang Dong, Yan-Rong Su, Xiong-Hui Zhou, Feng-Xia Liu. Discovering common pathogenetic processes between COVID-19 and sepsis by bioinformatics and system biology approach. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.975848
|
| 16 |
Gian Mario Cortes, Maria Antonietta Marcialis, Flaminia Bardanzellu, Angelica Corrias, Vassilios Fanos, Michele Mussap. Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.856165
|
| 17 |
Enrik John T. Aguila, Ian Homer Y. Cua, Rajvinder Singh. Effects of coronavirus disease 2019 on the digestive system and its nutritional implications. Current Opinion in Clinical Nutrition & Metabolic Care 2021; 24(5): 440 doi: 10.1097/MCO.0000000000000785
|
| 18 |
Satyaki Roy, Shehzad Z. Sheikh, Terrence S. Furey. A machine learning approach identifies 5-ASA and ulcerative colitis as being linked with higher COVID-19 mortality in patients with IBD. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-95919-2
|
| 19 |
Keisuke Naito, Tomoyo Narita, Yukari Murata, Naoto Morimura. Risk factors associated with hospital transfer among mild or asymptomatic COVID-19 patients in isolation facilities in Tokyo: a case-control study. IJID Regions 2022; 2: 8 doi: 10.1016/j.ijregi.2021.11.001
|
| 20 |
Viktoriya Sokolova, Jana‐Fabienne Ebel, Sebastian Kollenda, Kai Klein, Benedikt Kruse, Claudia Veltkamp, Christian M. Lange, Astrid M. Westendorf, Matthias Epple. Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell Models. Small 2022; 18(31) doi: 10.1002/smll.202201167
|
| 21 |
Naser-Aldin Lashgari, Nazanin Momeni Roudsari, Saeideh Momtaz, Amir Hossein Abdolghaffari. Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment. World Journal of Gastroenterology 2021; 27(46): 7943-7955 doi: 10.3748/wjg.v27.i46.7943
|